## Core Concept
Autoimmune hepatitis type II is characterized by the presence of specific autoantibodies and a distinct clinical presentation. It is one of the three main types of autoimmune hepatitis, with type I being the most common. The condition involves an immune-mediated attack on liver cells.

## Why the Correct Answer is Right
The correct answer involves the identification of specific autoantibodies associated with autoimmune hepatitis type II. LKM-1 (Liver Kidney Microsome type 1) antibodies are hallmark autoantibodies for autoimmune hepatitis type II. These antibodies target specific cytochrome P450 enzymes in the liver and kidney. LC-1 (Liver Cytosol type 1) and LC-2 antibodies are also associated with this condition.

## Why Each Wrong Option is Incorrect
- **Option A: Antinuclear antibody** - This is more commonly associated with autoimmune hepatitis type I, along with antismooth muscle antibodies.
- **Option C: Antismooth muscle antibody** - Like antinuclear antibodies, these are typically found in autoimmune hepatitis type I.
- **Option D: DS DNA** - Double-stranded DNA antibodies are often seen in systemic lupus erythematosus (SLE) and not specifically characteristic of autoimmune hepatitis type II.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that autoimmune hepatitis type II, characterized by the presence of LKM-1 antibodies, often has a more severe course and is more frequently associated with acute presentation compared to type I.

## Correct Answer: B. LKM-1 antibody.